Related Experiment Video
Updated: Jul 5, 2025

13:34
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
8.4K
Esketamine enhances memory reconsolidation in the novel object recognition task
1The Brain Cognition and Brain Disease Branch, Pu Ai Medical School, Shaoyang University, 422000, Shaoyang, China.
Physiology & Behavior
|January 12, 2024
Summary
Esketamine enhances memory reconsolidation in mice by acting on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. This finding suggests potential therapeutic applications for esketamine in memory-related cognitive functions.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Science
Background:
- Esketamine, an FDA-approved antidepressant, has shown rapid effects in treatment-resistant depression.
- Its role in learning and memory, specifically memory reconsolidation, remains under-investigated.
- Understanding esketamine's impact on memory processes is crucial for its broader therapeutic potential.
Purpose of the Study:
- To evaluate the effect of esketamine on memory reconsolidation using the novel object recognition (NOR) task in mice.
- To determine the optimal timing for esketamine administration to influence memory reconsolidation.
- To investigate the involvement of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in esketamine's effects on memory.
Main Methods:
- Utilized a novel object recognition (NOR) memory task in 7-week-old male Institute of Cancer Research mice.
- Administered esketamine at different time points relative to memory reactivation (0 h vs. 6 h delay) and sampling (24 h without reactivation).
- Assessed the impact of esketamine on memory performance and measured locomotor activity to control for nonspecific effects. Investigated the role of AMPA receptors using the antagonist NBQX.
Main Results:
- Esketamine significantly enhanced NOR memory performance when administered 0 h after reactivation, but not after a 6 h delay.
- Administration of esketamine 24 h after sampling without reactivation did not improve memory performance.
- Esketamine did not affect locomotor activity or exploratory behavior, indicating specific effects on memory.
- The AMPA receptor antagonist NBQX blocked the memory-enhancing effects of esketamine.
Conclusions:
- Esketamine administration directly after memory reactivation markedly improves memory reconsolidation in the NOR task.
- The pro-mnemonic effect of esketamine is dependent on the timing of administration relative to memory reactivation.
- Esketamine's enhancement of memory reconsolidation is mediated through the activity of AMPA receptors.
Related Concept Videos
Role of Hippocampus in Memory
255
The hippocampus, a critical brain structure, plays an essential role in memory processing, particularly in the formation and retrieval of memory. This small, seahorse-shaped region is located within the medial temporal lobe, with one hippocampus in each brain hemisphere. Experimental studies involving lesions in the hippocampi of rats have demonstrated significant impairments in tasks such as object recognition and maze navigation, indicating the hippocampus involvement in both recognition and...
255
Role of Neurotransmitters in Memory
562
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
562

